{"symbol":"AMGN","fiscalQuarter":"Q1-2021","reportDate":"2021-04-27","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2021","postBrief":{"headline":"Amgen Misses on EPS, Stock Down 0.15%","keyNumbers":[{"metric":"EPS","actual":"$3.70","expected":"N/A","surprise":"-7.57%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced during the quarter.","They emphasized a focus on long-term growth despite short-term hurdles."],"summary":"Overall, management expressed caution regarding current market conditions. They highlighted the importance of maintaining a steady course amid uncertainties."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report shows a slight miss on EPS, which may raise concerns among investors about the company's short-term performance. The stock reacted with a minor decline of 0.15%, indicating a muted response from the market. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.","metaDescription":"Amgen Inc (AMGN) Q1 2021 earnings: EPS missed expectations. Stock down 0.15%. Full breakdown."}}